Literature DB >> 34378815

Plasminogen Regulates Fracture Repair by Promoting the Functions of Periosteal Mesenchymal Progenitors.

Luqiang Wang1,2, Lutian Yao1,3, Hao Duan4,5,6, Fan Yang4, Maohuan Lin4, Rongxin Zhang5, Zhenqiang He5, Jaimo Ahn1, Yi Fan5, Ling Qin1, Yanqing Gong4.   

Abstract

Defective or insufficient bone repair and regeneration are common in patients as a result of major trauma or severe disease. Cell therapy with periosteal mesenchymal progenitors, which can be limited in severe injury, serves as a promising approach; however, its efficacy is limited due to a repair-hostile ischemic tissue microenvironment after traumatic fracture. Here we report that plasminogen (Plg), a factor that is upregulated in these environments, is critical for fracture healing. Plg knockout mice had impaired trabecular and cortical bone structure and exhibited delayed and incomplete fracture healing. Interestingly, Plg deficiency greatly reduced the thickness of expanded periosteum, suggesting a role of Plg in periosteal mesenchymal progenitor-mediated bone repair. In culture, Plg increased cell proliferation and migration in periosteal mesenchymal progenitors and inhibited cell death under ischemic conditions. Mechanistically, we revealed that Plg cleaved and activated Cyr61 to regulate periosteal progenitor function. Thus, our study uncovers a cellular mechanism underlying fracture healing, by which Plg activates Cyr61 to promote periosteal progenitor proliferation, survival, and migration and improves bone repair after fracture. Targeting Plg may offer a rational and effective therapeutic opportunity for improving fracture healing.
© 2021 American Society for Bone and Mineral Research (ASBMR). © 2021 American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  BONE MODELING AND REMODELING; CYR61; FRACTURE HEALING; PERIOSTEAL PROGENITORS; PLASMINOGEN

Mesh:

Substances:

Year:  2021        PMID: 34378815      PMCID: PMC8865375          DOI: 10.1002/jbmr.4423

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  53 in total

1.  Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway.

Authors:  Usha R Pendurthi; Mylinh Ngyuen; Patricia Andrade-Gordon; Lars C Petersen; L Vijaya Mohan Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-09-01       Impact factor: 8.311

2.  Plasminogen regulates cardiac repair after myocardial infarction through its noncanonical function in stem cell homing to the infarcted heart.

Authors:  Yanqing Gong; Yujing Zhao; Ying Li; Yi Fan; Jane Hoover-Plow
Journal:  J Am Coll Cardiol       Date:  2014-03-26       Impact factor: 24.094

3.  Plasminogen activators are involved in the degradation of bone by osteoclasts.

Authors:  Vincent Everts; Evis Daci; Wikky Tigchelaar-Gutter; Kees A Hoeben; Sophie Torrekens; Geert Carmeliet; Wouter Beertsen
Journal:  Bone       Date:  2008-07-21       Impact factor: 4.398

Review 4.  Fracture healing under healthy and inflammatory conditions.

Authors:  Lutz Claes; Stefan Recknagel; Anita Ignatius
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

5.  A novel mechanism of plasmin-induced mitogenesis in fibroblasts.

Authors:  S K Mandal; L V M Rao; T T T Tran; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2005-01       Impact factor: 5.824

6.  Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.

Authors:  Hiroto Matsuoka; Thomas H Sisson; Teruaki Nishiuma; Richard H Simon
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-13       Impact factor: 6.914

7.  Secretome from mesenchymal stem cells induces angiogenesis via Cyr61.

Authors:  Rosendo Estrada; Na Li; Harshini Sarojini; Jin An; Menq-Jer Lee; Eugenia Wang
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

8.  Recombinant human parathyroid hormone (PTH 1-34) and low-intensity pulsed ultrasound have contrasting additive effects during fracture healing.

Authors:  Stuart J Warden; David E Komatsu; Johanna Rydberg; Julie L Bond; Sean M Hassett
Journal:  Bone       Date:  2008-11-21       Impact factor: 4.398

9.  Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.

Authors:  Shr-Jeng Leu; Stephen C-T Lam; Lester F Lau
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

10.  Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.

Authors:  J A Yee; L Yan; J C Dominguez; E H Allan; T J Martin
Journal:  J Cell Physiol       Date:  1993-12       Impact factor: 6.384

View more
  1 in total

Review 1.  Periosteal Skeletal Stem and Progenitor Cells in Bone Regeneration.

Authors:  Simon Perrin; Céline Colnot
Journal:  Curr Osteoporos Rep       Date:  2022-07-13       Impact factor: 5.163

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.